Preclinical Toxicology of rQNestin34.5v.2: An Oncolytic Herpes Virus with Transcriptional Regulation of the ICP34.5 Neurovirulence Gene is a research paper published in Molecular Therapy — Methods & Clinical Development (2020). On theSindex it has a DataRank of 2.0. It has been cited 84 times, with 74 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.666
From this paper's citation signal
Citation Network Contribution
1.4
From 69 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 74 citers.
National Institutes of Health
Grant: P01CA163205
National Institutes of Health
Grant: P01CA236749
National Institutes of Health
Grant: R01NS110942
National Institutes of Health
Grant: U01NS061811
National Institutes of Health
Grant: 3P01CA163205-03S1
Circumventing Barriers to Effective Oncolytic Virotherapy of Malignant Gliomas
National Institutes of Health
Grant: 1P01CA236749-01A1
Understanding and Overcoming T cell Immunosuppression in Glioblastoma
National Institutes of Health
Grant: 5R01NS110942-05
Oncolytic virus therapeutic responses occur from changes in the glioblastoma immune microenvironment
National Institutes of Health
Grant: 7U01NS061811-05
Preclinical Toxicity Evaluation of a Potent Oncolytic Virus
U.S. Department of Defense
American Brain Tumor Association
National Brain Tumor Society
Neurosurgery Research and Education Foundation
Alliance for Cancer Gene Therapy
Fields of Study
Keywords
Sustainable Development Goals